Pacira BioSciences, Inc. (PCRX)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	745,130	509,994	498,334	866,048	651,623
Total current liabilities	US$ in thousands	309,920	97,383	147,774	521,118	253,328
Current ratio		2.40	5.24	3.37	1.66	2.57

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $745,130K ÷ $309,920K
= 2.40

The current ratio of Pacira BioSciences, Inc. has shown fluctuations over the past five years.

As of December 31, 2020, the current ratio was 2.57, indicating that the company had $2.57 in current assets for every $1 in current liabilities. This suggests a healthy liquidity position.

However, by December 31, 2021, the current ratio decreased to 1.66, signaling a decline in short-term liquidity compared to the previous year. This may raise concerns about the company's ability to cover its short-term obligations.

In the following years, the current ratio improved significantly, reaching 3.37 by December 31, 2022, and further increasing to 5.24 by December 31, 2023. These higher ratios indicate a stronger ability to meet current liabilities with current assets.

By December 31, 2024, the current ratio dropped to 2.40, although it remained above 2, which is generally considered acceptable. Overall, while there have been fluctuations, Pacira BioSciences' current ratio indicates a generally healthy liquidity position over the five-year period with some fluctuations.